Goldman Sachs’s Surgery Partners SGRY Stock Holding History
Bought
Maintained
Sold
Other funds holding SGRY
BCI
JT
PCM
KSCM
Goldman Sachs's SGRY Position: Q2 2026 in Review
Goldman Sachs reduced its Surgery Partners (SGRY) stake by 16% in Q2 2026, selling an estimated $2.82M and leaving 1,079,626 shares worth $18.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2738.
Goldman Sachs first reported a position in SGRY in Q4 2015 and has held it in 38 quarters since. The position peaked at $43M in Q2 2023. 188 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.
- Goldman Sachs held 1,079,626 shares of Surgery Partners worth $18.1M as of Q2 2026.
- Goldman Sachs sold 200,926 Surgery Partners shares in Q2 2026, an estimated $2.82M.
- Surgery Partners made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2738 holding.
- Goldman Sachs first reported a position in Surgery Partners in Q4 2015 and has held it in 38 quarters since.
- Goldman Sachs's Surgery Partners position peaked at $43M in Q2 2023.
- 188 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.